Our findings elucidate the functional alterations of CCT and precursor cells within the context of HCC. The novel prognostic framework provides actionable insights for stratifying patients likely to benefit from combinatorial immunotherapy and chemotherapy.
Ran et al. (Thu,) studied this question.